Scholars Central

Short communicationPublished 16 Jul 2024

NGS in Immunotherapy: Enhancing Efficacy and Safety of New Treatments

Authors: Tarunkanti Mondal

Department of Cell morphology, Jaipur National University, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Next-generation sequencing (NGS) is revolutionizing the field of immunotherapy, offering unprecedented insights into the genetic and molecular landscapes of cancer and immune cells. This advanced technology enables the precise identification of genetic mutations, neoantigens, and immune-related biomarkers, which are critical for developing personalized immunotherapies. By facilitating a deeper understanding of tumor heterogeneity and the tumor microenvironment, NGS aids in the design of more effective and targeted treatments. Moreover, NGS plays a pivotal role in monitoring treatment responses and detecting minimal residual disease, thereby improving the safety and efficacy of immunotherapeutic approaches. This review explores the transformative impact of NGS on immunotherapy, highlighting its contributions to patient stratification, therapeutic targeting, and the development of novel immunotherapeutic strategies. The integration of NGS into clinical practice promises to enhance the precision of immunotherapy, ultimately leading to better patient outcomes and advancing the frontier of cancer treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Analytical & Bioanalytical Techniques
  • SubjectBiochemistry & Biotechnology
  • SubjectChemistry
  • BylineArticles whose byline prints “Tarunkanti Mondal”